CNBX
CNBX Pharmaceuticals Inc.$0.000200 +0.00 (+100.00%)
Oct 26 4:00 PM ET · prev $0.00010000
1 year
−33.3%
from $0.000300 · Oct 28
30 days
+100.0%
from $0.00010000
52-week range
$0.00010000–0.000700
−71% from high · low Feb 23
Avg volume 20D
11.86M
Oct 22 spike 70.04M
Short interest
1
−100.0%
Days to cover
1.0
at average volume
Filing reports
1
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Jul 31 Short interest jumps 100000.0% to 1.44M
- X Aug 31 Short interest falls 39.0% to 788.9K
- X Sep 15 Short interest falls 87.3% to 100.0K
- X Sep 30 Short interest falls 30.0% to 70.0K
- X Oct 15 Short interest falls 100.0% to 1
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −100.0% to 1 shares. 1.0 days to cover.
- TrendUPTREND
51% above its 50-day average. New closing low $0.00010000 on Oct 23.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | None | None | No data | $0.00 |
| Next Q | None | None | No data | $0.00 |
| Current FY | None | None | No data | $0.00 |
| Next FY | None | None | No data | $0.00 |
Short side
FINRA· Oct 15, 20261
shares short
-100.0%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Oct 1, 2026 SEC
CNBX Pharmaceuticals dismissed its auditor, Elkana Amitai CPA, and hired Vilki & Co., a firm based in Gujarat, India…
8-K · Impact 5/10
Jul 13, 2026 Earnings calendar
CNBX Q3 2026 Earnings Scheduled — 2026-07-13
SecBot reports
1 filing · 0 bullish · 1 bearishAll CNBX filing & press-release reports (1)
- 8-K reportOct 1, 2026